Skip to Main Content
 Search | Directories | Reference Tools
UW Home > Discover UW > Research >  
Researcher's Guide

Grant Life Cycle

    Forms | Rules and Policy | Fact Sheets | Training | Sponsors | eTools
News
sitemap | contact us | glossary

 

http://www.washington.edu/news/2013/11/14/fda-approved-immune-modulating-drug-unexpectedly-benefits-mice-with-fatal-mitochondrial-defect/?utm_source=rss&utm_medium=rss&utm_campaign=fda-approved-immune-modulating-drug-unexpectedly-benefits-mice-with-fatal-mitochondrial-defect

Posted on January 11, 2014 at 1:18pm

The transplant anti-rejection drug rapamycin showed unexpected benefits in a mouse model of a fatal defect in the energy powerhouses of cells, the mitochondria. Children with the condition, Leigh syndrome, show progressive brain damage, muscle weakness, lack of coordination or muscle control, and weight loss, and usually succumb to respiratory failure. Read the full article in UW Today,

More Announcements [...]